Table 5 Oral site and p16INK4A and HSV co-expression
From: HPV related p16INK4A and HSV in benign and potentially malignant oral mucosa pathologies
Oral cavity localisation | p16INK4A + | p16INK4A + and HSV + (co-expression) | Total |
|---|---|---|---|
Cheek | 26 | 6 | 32 |
68,42% | 28,57% | ||
Lip | 0 | 5 | 5 |
0,00% | 23,81% | ||
Tongue | 5 | 7 | 12 |
13,16% | 33,33% | ||
Gingiva | 7 | 0 | 7 |
18,42% | 0,00% | ||
Hard palate | 0 | 2 | 2 |
0,00% | 9,52% | ||
Soft palate (oropharynx) | 0 | 1 | 1 |
0,00% | 4,76% | ||
Summary | 38 | 21 | 59 |